THOMAS H. GLOCER - 30 Jun 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
Director
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Thomas H. Glocer
Issuer symbol
MRK
Transactions as of
30 Jun 2022
Net transactions value
+$45,000
Form type
4
Filing time
05 Jul 2022, 14:07:37 UTC
Previous filing
03 Jun 2022
Next filing
04 Oct 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 5,100 30 Jun 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Phantom Stock Award $45,000 +494 +0.59% $91.17 84,209 30 Jun 2022 Common Stock 494 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1-for-1
F2 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
F3 Holdings include shares acquired in dividend reinvestment transactions.